BUY Nippon Life India Asset Management Ltd — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))19 Aug 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 advisors have active intraday BUY calls on this stock, all issued in the last 14 days
Advisor consensus · adjacent horizon·20 Aug · today
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·20 Aug · today
Nippon Life India AMC Share Price: తొలి క్వార్టర్ లోనే లాభాల్లో భారీ జంప్.. షేర్ **2%** ర్యాలీ!
NewsGoogle News·17 Aug · 2d ago
Nippon Life India AMC Shares Gain 2% After Q1 Profit Rises 27%
NewsGoogle News·17 Aug · 2d ago
Nippon Life India AMC ஷேர் விலை உயர்வு: Q1 லாபம் **27%** அதிகரிப்பு!
NewsGoogle News·17 Aug · 2d ago
Nippon, HDFC AMC: ஜூலை மாத முதலீடுகள் குறைந்தாலும் Nomura 'Buy' ரேட்டிங்!
NewsGoogle News·13 Aug · 6d ago
Nomura का HDFC AMC और Nippon Life India AMC पर भरोसा कायम, जुलाई के कम इनफ्लो के बावजूद 'Buy' रेटिंग
NewsGoogle News·13 Aug · 6d ago
Nippon Life India Asset Management Ltd provided an intimation regarding an ESG Rating by NSE Sustainability Ratings and Analytics Limited.
BSE · Company Update·11 Aug · 1w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Nippon Life India Asset Management
- SELL — Sachin Janardan Sarvade, IDBI Capital Markets and Securities23 Oct 2026 · ~2 weeks · target ₹800 · Active
- BUY — Elara Capital23 Oct 2026 · ~1 year · target ₹1,165 · Active
- BUY — Siddharth Rai Mangala16 Oct 2026 · Same day · target ₹1,125 · SL hit
- SELL — Ashish Bahety, Profitmart Securities7 Oct 2026 · ~2 weeks · target ₹1,000 · SL hit
- SELL — Gaurav Sharma, Globe Capital Market30 Sept 2026 · ~2 weeks · target ₹1,000 · Expired
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

